OnKure Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +35.1% | +958.0% | +5.9% | +18.2% | +25.4% | |
| – | – | – | – | – | – | |
| – | +76.8% | -8.0% | +24.2% | +36.4% | +10.2% | |
| – | – | – | +23.4% | +119.8% | +38.7% | |
| – | +103.8% | -25.2% | +24.1% | +47.3% | +14.2% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | -97.3% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.